Merck & Co Inc
The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]
Read More
Jim Cramer says the tech sell-off proves why this old investing rule still matters
The action on Wall Street this week is a reminder of the importance of portfolio diversification, CNBC’s Jim Cramer said Wednesday, as tech-only portfolios have been getting beaten down during the bout of volatility. “Tech’s a good part of the market, it’s just that many of these stocks suddenly aren’t worth as much as we […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and more
Check out the companies making headlines before the bell: Novo Nordisk — The maker of obesity drug Wegovy’s U.S. stock fell about 13% after unexpectedly warning that fiscal 2026 sales will be hurt by lower drug prices in the U.S. even as it anticipates more patients will use its popular GLP-1 drug. Novo Nordisk said […]
Read More
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms
Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. But the company posted a modest 2026 outlook that fell short of Wall Street’s expectations as it prepares for a few drugs to lose patent protection later this year and face generic […]
Read More
The xAI-SpaceX merger, Palantir earnings, China’s frowning horses and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Tuesday. I did my workout studio’s Hyrox-themed class yesterday, which not only left me sore but also with a better understanding of what all the hype in the fitness business is about. S&P 500 futures ticked higher this morning. The stock […]
Read More
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more
Check out the companies making headlines before the bell: Palantir — The stock jumped 11% following the AI-powered software provider’s fourth-quarter earnings beat . Palantir reported adjusted earnings of 25 cents per share, versus the 23 cents expected from analysts polled by LSEG. Revenue was $1.41 billion, topping the $1.33 billion consensus estimate. Merck — […]
Read More
We just got reasons to love these 2 portfolio stocks even more
Investors have a couple of new reasons to like portfolio stocks Broadcom and Goldman Sachs . Deal king: Coterra named Goldman Sachs as a financial advisor on its $58 billion all-stock merger with fellow shale producer Devon . The deal is the largest in the energy sector since Diamondback ‘s $26 billion acquisition of Endeavor […]
Read More
The metal sell-off, Disney earnings, the ‘Melania’ movie and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. America’s favorite groundhog, Punxsutawney Phil, saw his shadow this morning, meaning we’re in for six more weeks of winter. After the recent string of cold temperatures, I can’t say I’m surprised. Stock futures are sliding this morning. The three major […]
Read More
Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data
The stock market is well-positioned to bounce next week if the heavyweight companies set to report earnings deliver strong numbers, CNBC’s Jim Cramer said Friday. That’s because the market ended the week on a subdued note, the “Mad Money” host said, after the S&P 500 finished in the red for three straight days. The busy […]
Read More
Stocks making the biggest moves midday: GameStop, Booz Allen, CVR Energy, CoreWeave & more
Check out some of the companies making the biggest midday moves: Booz Allen Hamilton — The consulting firm shed more than 5% after the Treasury Department said it canceled all contracts with the company , whose employees leaked the tax records of President Donald Trump, and the billionaires Jeff Bezos and Elon Musk, to media […]
Read More